
The FDA removed the PCNSL limitation of use from the liso-cel label in LBCL, making it the second CAR T-cell therapy with this update.
Marco Davila, MD, PhD, discusses how to shape the future of medicine with gene and cell therapy.
Marco Davila, MD, PhD, discusses how to shape the future of medicine with gene and cell therapy.


